ResMed Inc. vs Super Micro Computer Inc — how do they compare? ResMed Inc. trades at $194.34 (market cap $28.81B), while Super Micro Computer Inc trades at $30.26 (market cap $15.41B). The key difference: ResMed Inc. is the larger of the two by market cap, and ResMed Inc. pays a 1.21% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.
| RMD | SMCI | |
|---|---|---|
Market Cap | $28.81B | $15.41B |
Sector | Health | Technology |
52-Week High | $293.73 | $60.71 |
52-Week Low | $182.82 | $20.53 |
Enterprise Value | $27.99B | $22.93B |
Dividend Yield | 1.21% | — |
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $195.8, down 1.6% on the day, with a bearish technical signal but strong fundamentals. Recent quarterly earnings have consistently beaten estimates, with Q1 2026 EPS of $2.86 exceeding the $2.80 forecast. The company sold its MatrixCare business for $490 million in July 2026 to sharpen focus on connected care, signaling strategic refinement. Revenue growth remains robust, climbing to $5.15 billion in 2025, with net income margins expanding to 27.44%.
The outlook is supported by solid earnings momentum and a consensus price target of $245.88, implying 25.6% upside. Risks include competitive pressures in medical equipment and reliance on sleep apnea market growth. Analyst sentiment is mixed with 40% buy ratings, but institutional selling by Baader Bank in Q1 2026 warrants monitoring.
Super Micro Computer (SMCI) trades at $23.83, down 1.41% on the day, with technical indicators showing bearish momentum despite recent positive earnings beats. The company reported strong Q1 2026 results with EPS of $0.84 beating expectations of $0.617, while preliminary Q4 guidance indicates significant margin expansion to 15-17% and over $60 billion in new orders. Valuation metrics remain attractive with P/E of 12.54 and P/S of 0.47, though cash flow trends show volatility with 2026 projections indicating operational challenges.
The outlook appears cautiously optimistic with analyst consensus price target of $36.71 representing 54% upside potential, though technical weakness and competitive pressures in AI hardware create near-term headwinds. Key risks include execution on massive order backlog, margin sustainability, and intense competition from Dell and HPE in the AI server market.
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →